肝动脉化疗栓塞术联合中药治疗中晚期肝癌的临床研究_李俊.pdfVIP

网络出版时间：2013-11-06 11:47 网络出版地址：/kcms/detail/11.4894.R1147.013.html 肝动脉化疗栓塞术联合中药治疗中晚期肝癌的 临床研究 李 俊，戚春厚 （山东省临沂市沂水中心医院介入科，山东 沂水 276400 ） [摘要] 目的：探讨中药联合肝动脉化疗栓塞术（TACE ）治疗中晚期肝癌的临床疗效。方法：将105 例肝癌患者随机分 为研究组和对照组，研究组43 例，行TACE 时灌注中药艾迪注射液50 ml ，术后第10 天均口服复方斑蝥胶囊及鸦胆子油口 服液；对照组62 例，仅行TACE 术。对2 组患者的生存率、生活质量进行6、12、24、36 个月 的随访。结果：研究组和对 照组患者术后6、12、24、36 个月生存率分别为88.37％、81.4 ％、61.52 ％、39.53～与 85.74％、73.02 ％、58.73 ％、33.33%； 研究组生存率高于对照组，有一定的生存优势，生存期内研究组生活质量明显好于对照组。结论：中药联合TACE 治疗中晚 期肝脏恶性肿瘤可改善机体免疫功能，减轻化疗药不良反应，明显延长患者的生存期，提高患者的生活质量。 [关键词] 中药；化疗栓塞；肝肿瘤 [中图分类号] R735.7； [文献标识码] A DOI: 10.3969/j.issn.1672-0512.2013.06. Clinical Efficacy of Transcatheter Artery Chemoembolization Combined Traditional Chinese Medicine for the Treatment of Primary Liver Cancer LI Jun, QI Chun-hou Department of Intervention, Linyi City Yishui Central Hospital Yishui, 276400, China [Abstract] Objective: To evaluate clinical efficacy of transcatheter artery chemoembolization combined traditional chinese medicine for the treatment of primary liver cancer. Methods: 105 patients with primary liver cancer, who had lost opportunity of operation, were divided into the research group and control group randomly, with 43 patients in research group and 63patients in control group. 43 patients of the research group were treated by TACE with Aidi zhusheye, the research group patients were tr eated by TACE and Fu fang ban mao capsules plus Yadanziyou Koufu Ruye. The control group was treated only by TACE. Both groups were followed up at 6, 12, 24, 36months. Results: the research group and control group 6-m, 12-m, 24-m, 36-m survival rates were